BTK inhibition in UDSCC5 cells, which secrete the highest amounts of VEGFA in comparison to all other tested HNSCC-derived cell lines (data not shown), resulted in a distinct reduction in VEGFA secretion after 96h of treatment with AVL-292 (Figure 2B). The gene discussed is BTK; the disease is head and neck squamous cell carcinoma.